Eve Burstein
Stock Analyst at Bernstein
(1.59)
# 3,332
Out of 4,915 analysts
23
Total ratings
38.46%
Success rate
-0.08%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $118.05 | +5.89% | 4 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $140.96 | +41.88% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $90.85 | +59.60% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $299.07 | +20.37% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $46.80 | +92.31% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $45.19 | -22.55% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $477.28 | +29.90% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.49 | +67.79% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $13.80 | +59.42% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $106.66 | +4.07% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $118.05
Upside: +5.89%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $140.96
Upside: +41.88%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $90.85
Upside: +59.60%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $299.07
Upside: +20.37%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $46.80
Upside: +92.31%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $45.19
Upside: -22.55%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $477.28
Upside: +29.90%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.49
Upside: +67.79%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $13.80
Upside: +59.42%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $106.66
Upside: +4.07%